Xebio Holdings Co., Ltd. Logo

Xebio Holdings Co., Ltd.

8281.T

(3.0)
Stock Price

1.099,00 JPY

1.57% ROA

2.72% ROE

15.54x PER

Market Cap.

52.329.560.348,00 JPY

4% DER

2.51% Yield

1.38% NPM

Xebio Holdings Co., Ltd. Stock Analysis

Xebio Holdings Co., Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Xebio Holdings Co., Ltd. Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (0.34x) suggests it's undervalued, making it an attractive opportunity for investors.

2 DER

The stock has a low debt to equity ratio (13%), which means it has a small amount of debt compared to the ownership it holds

3 Net Profit Growth

This company has consistently achieved strong net profit growth over the past five years, demonstrating a solid financial performance and making it an appealing investment option.

4 ROE

ROE in an average range (4.45%) suggests satisfactory profitability and decent utilization of shareholders' equity.

5 ROA

The stock's ROA (2.6%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

6 Revenue Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

7 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

8 Dividend

The company's consistent dividend payments over the past three years indicate a strong commitment to delivering returns to investors.

9 Buffet Intrinsic Value

The company's stock shows potential as it is undervalued (145.782) according to Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

10 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

11 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

Xebio Holdings Co., Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Xebio Holdings Co., Ltd. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Xebio Holdings Co., Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Xebio Holdings Co., Ltd. Revenue
Year Revenue Growth
2004 96.749.000.000
2005 121.048.000.000 20.07%
2006 132.227.000.000 8.45%
2007 144.515.000.000 8.5%
2008 154.159.000.000 6.26%
2009 163.664.000.000 5.81%
2010 170.183.000.000 3.83%
2011 181.577.000.000 6.28%
2012 192.628.000.000 5.74%
2013 204.779.000.000 5.93%
2014 210.672.000.000 2.8%
2015 221.391.000.000 4.84%
2016 223.353.000.000 0.88%
2017 234.595.000.000 4.79%
2018 231.629.000.000 -1.28%
2019 225.312.000.000 -2.8%
2020 202.438.000.000 -11.3%
2021 223.282.000.000 9.34%
2022 239.293.000.000 6.69%
2023 231.144.000.000 -3.53%
2023 242.433.000.000 4.66%
2024 260.568.000.000 6.96%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Xebio Holdings Co., Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
2004 0
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Xebio Holdings Co., Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
2004 0
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 53.142.000.000 100%
2013 58.413.000.000 9.02%
2014 64.231.000.000 9.06%
2015 68.563.000.000 6.32%
2016 70.259.000.000 2.41%
2017 72.702.000.000 3.36%
2018 73.128.000.000 0.58%
2019 74.420.000.000 1.74%
2020 67.539.000.000 -10.19%
2021 72.389.000.000 6.7%
2022 73.634.000.000 1.69%
2023 0 0%
2023 76.891.000.000 100%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Xebio Holdings Co., Ltd. EBITDA
Year EBITDA Growth
2004 12.890.000.000
2005 12.721.000.000 -1.33%
2006 12.927.000.000 1.59%
2007 13.357.000.000 3.22%
2008 15.258.000.000 12.46%
2009 15.920.000.000 4.16%
2010 17.489.000.000 8.97%
2011 19.866.000.000 11.97%
2012 18.734.000.000 -6.04%
2013 19.502.000.000 3.94%
2014 13.018.000.000 -49.81%
2015 12.747.000.000 -2.13%
2016 13.641.000.000 6.55%
2017 16.887.000.000 19.22%
2018 11.289.000.000 -49.59%
2019 10.334.000.000 -9.24%
2020 8.926.000.000 -15.77%
2021 12.217.000.000 26.94%
2022 13.515.000.000 9.6%
2023 2.192.000.000 -516.56%
2023 9.297.000.000 76.42%
2024 20.776.000.000 55.25%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Xebio Holdings Co., Ltd. Gross Profit
Year Gross Profit Growth
2004 35.315.000.000
2005 43.301.000.000 18.44%
2006 49.621.000.000 12.74%
2007 55.135.000.000 10%
2008 59.613.000.000 7.51%
2009 62.202.000.000 4.16%
2010 65.731.000.000 5.37%
2011 71.731.000.000 8.36%
2012 75.491.000.000 4.98%
2013 81.403.000.000 7.26%
2014 80.851.000.000 -0.68%
2015 85.612.000.000 5.56%
2016 89.172.000.000 3.99%
2017 92.762.000.000 3.87%
2018 87.897.000.000 -5.53%
2019 88.727.000.000 0.94%
2020 78.820.000.000 -12.57%
2021 87.054.000.000 9.46%
2022 91.774.000.000 5.14%
2023 86.240.000.000 -6.42%
2023 88.497.000.000 2.55%
2024 103.912.000.000 14.83%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Xebio Holdings Co., Ltd. Net Profit
Year Net Profit Growth
2004 3.392.000.000
2005 6.996.000.000 51.52%
2006 7.288.000.000 4.01%
2007 8.342.000.000 12.63%
2008 6.105.000.000 -36.64%
2009 6.355.000.000 3.93%
2010 4.618.000.000 -37.61%
2011 7.772.000.000 40.58%
2012 6.332.000.000 -22.74%
2013 6.618.000.000 4.32%
2014 2.084.000.000 -217.56%
2015 2.118.000.000 1.61%
2016 2.991.000.000 29.19%
2017 4.249.000.000 29.61%
2018 1.884.000.000 -125.53%
2019 408.000.000 -361.76%
2020 412.000.000 0.97%
2021 3.836.000.000 89.26%
2022 5.397.000.000 28.92%
2023 136.000.000 -3868.38%
2023 2.592.000.000 94.75%
2024 11.140.000.000 76.73%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Xebio Holdings Co., Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2004 110
2005 228 52.19%
2006 159 -43.4%
2007 182 12.64%
2008 133 -36.84%
2009 141 5.67%
2010 103 -38.24%
2011 173 40.7%
2012 141 -22.86%
2013 147 4.11%
2014 46 -217.39%
2015 47 0%
2016 67 30.3%
2017 95 30.53%
2018 42 -126.19%
2019 9 -366.67%
2020 9 0%
2021 87 89.53%
2022 122 29.51%
2023 0 0%
2023 59 100%
2024 253 76.98%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Xebio Holdings Co., Ltd. Free Cashflow
Year Free Cashflow Growth
2004 -2.038.000.000
2005 8.194.000.000 124.87%
2006 -9.463.000.000 186.59%
2007 4.969.000.000 290.44%
2008 -6.216.000.000 179.94%
2009 7.945.000.000 178.24%
2010 6.885.000.000 -15.4%
2011 8.635.000.000 20.27%
2012 -2.110.000.000 509.24%
2013 5.720.000.000 136.89%
2014 921.000.000 -521.06%
2015 -275.000.000 434.91%
2016 5.666.000.000 104.85%
2017 -6.734.000.000 184.14%
2018 4.026.000.000 267.26%
2019 -6.513.000.000 161.81%
2020 20.128.000.000 132.36%
2021 -2.781.000.000 823.77%
2022 1.378.000.000 301.81%
2023 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Xebio Holdings Co., Ltd. Operating Cashflow
Year Operating Cashflow Growth
2004 -109.000.000
2005 11.953.000.000 100.91%
2006 7.082.000.000 -68.78%
2007 9.602.000.000 26.24%
2008 2.724.000.000 -252.5%
2009 12.476.000.000 78.17%
2010 11.910.000.000 -4.75%
2011 14.221.000.000 16.25%
2012 3.092.000.000 -359.93%
2013 12.385.000.000 75.03%
2014 7.424.000.000 -66.82%
2015 5.138.000.000 -44.49%
2016 10.444.000.000 50.8%
2017 -3.887.000.000 368.69%
2018 7.572.000.000 151.33%
2019 -1.305.000.000 680.23%
2020 25.369.000.000 105.14%
2021 2.235.000.000 -1035.08%
2022 7.020.000.000 68.16%
2023 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Xebio Holdings Co., Ltd. Capital Expenditure
Year Capital Expenditure Growth
2004 1.929.000.000
2005 3.759.000.000 48.68%
2006 16.545.000.000 77.28%
2007 4.633.000.000 -257.11%
2008 8.940.000.000 48.18%
2009 4.531.000.000 -97.31%
2010 5.025.000.000 9.83%
2011 5.586.000.000 10.04%
2012 5.202.000.000 -7.38%
2013 6.665.000.000 21.95%
2014 6.503.000.000 -2.49%
2015 5.413.000.000 -20.14%
2016 4.778.000.000 -13.29%
2017 2.847.000.000 -67.83%
2018 3.546.000.000 19.71%
2019 5.208.000.000 31.91%
2020 5.241.000.000 0.63%
2021 5.016.000.000 -4.49%
2022 5.642.000.000 11.1%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Xebio Holdings Co., Ltd. Equity
Year Equity Growth
2004 67.811.000.000
2005 72.919.000.000 7.01%
2006 78.598.000.000 7.23%
2007 85.426.000.000 7.99%
2008 88.795.000.000 3.79%
2009 94.067.000.000 5.6%
2010 97.453.000.000 3.47%
2011 103.966.000.000 6.26%
2012 109.763.000.000 5.28%
2013 114.577.000.000 4.2%
2014 115.778.000.000 1.04%
2015 115.646.000.000 -0.11%
2016 116.778.000.000 0.97%
2017 119.679.000.000 2.42%
2018 118.480.000.000 -1.01%
2019 117.249.000.000 -1.05%
2020 116.350.000.000 -0.77%
2021 118.705.000.000 1.98%
2022 122.566.000.000 3.15%
2023 124.010.000.000 1.16%
2023 124.813.000.000 0.64%
2024 126.378.000.000 1.24%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Xebio Holdings Co., Ltd. Assets
Year Assets Growth
2004 95.754.000.000
2005 117.106.000.000 18.23%
2006 122.080.000.000 4.07%
2007 133.123.000.000 8.3%
2008 138.663.000.000 4%
2009 148.293.000.000 6.49%
2010 152.566.000.000 2.8%
2011 164.759.000.000 7.4%
2012 167.793.000.000 1.81%
2013 181.383.000.000 7.49%
2014 181.698.000.000 0.17%
2015 180.865.000.000 -0.46%
2016 188.744.000.000 4.17%
2017 188.131.000.000 -0.33%
2018 184.054.000.000 -2.22%
2019 182.921.000.000 -0.62%
2020 207.482.000.000 11.84%
2021 208.308.000.000 0.4%
2022 211.300.000.000 1.42%
2023 207.157.000.000 -2%
2023 210.397.000.000 1.54%
2024 215.980.000.000 2.58%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Xebio Holdings Co., Ltd. Liabilities
Year Liabilities Growth
2004 27.943.000.000
2005 44.187.000.000 36.76%
2006 43.482.000.000 -1.62%
2007 47.697.000.000 8.84%
2008 49.868.000.000 4.35%
2009 54.226.000.000 8.04%
2010 55.113.000.000 1.61%
2011 60.793.000.000 9.34%
2012 58.030.000.000 -4.76%
2013 66.806.000.000 13.14%
2014 65.920.000.000 -1.34%
2015 65.219.000.000 -1.07%
2016 71.966.000.000 9.38%
2017 68.452.000.000 -5.13%
2018 65.574.000.000 -4.39%
2019 65.672.000.000 0.15%
2020 91.132.000.000 27.94%
2021 89.603.000.000 -1.71%
2022 88.734.000.000 -0.98%
2023 83.147.000.000 -6.72%
2023 85.580.000.000 2.84%
2024 89.599.000.000 4.49%

Xebio Holdings Co., Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
5569.58
Net Income per Share
76.97
Price to Earning Ratio
15.54x
Price To Sales Ratio
0.21x
POCF Ratio
7.3
PFCF Ratio
7.25
Price to Book Ratio
0.42
EV to Sales
0.14
EV Over EBITDA
3.95
EV to Operating CashFlow
4.67
EV to FreeCashFlow
4.67
Earnings Yield
0.06
FreeCashFlow Yield
0.14
Market Cap
52,33 Bil.
Enterprise Value
33,68 Bil.
Graham Number
2225.79
Graham NetNet
-32.64

Income Statement Metrics

Net Income per Share
76.97
Income Quality
2.79
ROE
0.03
Return On Assets
0.02
Return On Capital Employed
0.04
Net Income per EBT
0.59
EBT Per Ebit
1.06
Ebit per Revenue
0.02
Effective Tax Rate
0.39

Margins

Sales, General, & Administrative to Revenue
0.06
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.39
Operating Profit Margin
0.02
Pretax Profit Margin
0.02
Net Profit Margin
0.01

Dividends

Dividend Yield
0.03
Dividend Yield %
2.51
Payout Ratio
0
Dividend Per Share
30

Operating Metrics

Operating Cashflow per Share
163.93
Free CashFlow per Share
163.93
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.03
Return on Tangible Assets
0.02
Days Sales Outstanding
33.92
Days Payables Outstanding
136.59
Days of Inventory on Hand
208.74
Receivables Turnover
10.76
Payables Turnover
2.67
Inventory Turnover
1.75
Capex per Share
0

Balance Sheet

Cash per Share
636,18
Book Value per Share
2.869,40
Tangible Book Value per Share
2868.51
Shareholders Equity per Share
2860.73
Interest Debt per Share
116.72
Debt to Equity
0.04
Debt to Assets
0.02
Net Debt to EBITDA
-2.19
Current Ratio
1.92
Tangible Asset Value
126,34 Bil.
Net Current Asset Value
56,54 Bil.
Invested Capital
107050000000
Working Capital
70,09 Bil.
Intangibles to Total Assets
0
Average Receivables
23,01 Bil.
Average Payables
53,42 Bil.
Average Inventory
84516500000
Debt to Market Cap
0.1

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Xebio Holdings Co., Ltd. Dividends
Year Dividends Growth
2001 29
2002 29 0%
2003 29 0%
2004 20 -45%
2005 23 9.09%
2006 49 54.17%
2007 30 -60%
2008 30 0%
2009 30 0%
2010 30 0%
2011 30 0%
2012 18 -76.47%
2013 20 15%
2014 35 42.86%
2015 35 0%
2016 35 0%
2017 35 0%
2018 35 0%
2019 35 0%
2020 30 -16.67%
2021 30 0%
2022 30 0%
2023 30 0%
2024 30 0%
2025 0 0%

Xebio Holdings Co., Ltd. Profile

About Xebio Holdings Co., Ltd.

Xebio Holdings Co., Ltd., together with its subsidiaries, engages in sporting goods business in Japan. The company is involved in sporting goods retail activities, as well as the sale of sporting goods and apparels. It operates integrated mega specialty stores under The Super Sports XEBIO brand; small and medium scale sporting equipment specialty stores under the XEBIO Sports Express brand; urban sporting goods specialty stores under the Victoria brand; small-scale sporting goods stores under the NEXAS brand; sporting goods specialty stores under the Takeda Sports brand; golf products specialty stores under the Victoria Golf and Golf Partner brands; outdoor specialty stores under the L-Breath brand; and specialty apparel stores under the next and X'tyle brands. The company also operates sports eyewear stores under the X'tyleVision brand; health food and fitness, and medical products stores under the Xiasis brand; Free Blades, an ice hockey club team; Xebio Arena, a sports arena; and sports community station stores under the XSPOT brand. In addition, it engages in purchase and sale of golf goods; marketing project, research and consulting, event promotion, and property management activities; and international business, and research and development operations. Further, the company is involved in providing sports related digital platforms; and e-commerce management business. Additionally, it engages in sales agency business, human resource development, and temporary staffing service; and credit card business. The company was founded in 1962 and is headquartered in Koriyama, Japan.

CEO
Mr. Tomoyoshi Morohashi
Employee
2.560
Address
3-7-35 Asahi
Koriyama, 963-8024

Xebio Holdings Co., Ltd. Executives & BODs

Xebio Holdings Co., Ltd. Executives & BODs
# Name Age
1 Yuya Nakamura
Corporate Officer
70
2 Mr. Tomoyoshi Morohashi
Chief Executive Officer, President & Chairman
70
3 Takaaki Nakamura
Executive Vice President
70
4 Keita Shimanuki
Executive Vice President
70
5 Yasushi Konno
Executive Vice President
70

Xebio Holdings Co., Ltd. Competitors

YONEX Co., Ltd. Logo
YONEX Co., Ltd.

7906.T

(2.8)
JAMCO Corporation Logo
JAMCO Corporation

7408.T

(0.8)
Taiho Kogyo Co., Ltd. Logo
Taiho Kogyo Co., Ltd.

6470.T

(2.5)
SEED Co.,Ltd. Logo
SEED Co.,Ltd.

7743.T

(0.8)